Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription Articles published in Thromb Haemost Retrieve available abstracts of 47 articles: HTML format

Single Articles

September 2022
1. RIKKEN SAOF, Storey RF, Andreotti F, Clemmensen P, et al
   Parenteral Antiplatelet Drugs in ST-Elevation Myocardial Infarction: Current Status and Future Directions.
   Thromb Haemost. 2022 Sep 8. doi: 10.1055/s-0042-1753479.
   PubMed     Abstract available
   
   
   August 2022
2. BAMPATSIAS D, Mavroeidis I, Tual-Chalot S, Vlachogiannis NL, et al
   Beta-secretase-1 antisense RNA is associated with vascular ageing and atherosclerotic cardiovascular disease.
   Thromb Haemost. 2022 Aug 1. doi: 10.1055/a-1914-2094.
   PubMed     Abstract available
   
   
   June 2022
3. NOUMEGNI SR, Mansourati V, Tromeur C, Mao RL, et al
   Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study.
   Thromb Haemost. 2022 Jun 18. doi: 10.1055/s-0042-1748889.
   PubMed     Abstract available
   
   
   
4. ARASHI H, Yamaguchi J, Hagiwara N, Yasuda S, et al
   Rivaroxaban Underdose for Atrial Fibrillation with Stable Coronary Disease: The AFIRE Trial Findings.
   Thromb Haemost. 2022 Jun 13. doi: 10.1055/s-0042-1744543.
   PubMed     Abstract available
   
   
   
5. AKYEA RK, Georgiopoulos G, Iyen B, Kai J, et al
   Comparison of risk of serious cardiovascular events after haemorrhagic versus ischaemic stroke: a population-based study.
   Thromb Haemost. 2022 Jun 10. doi: 10.1055/a-1873-9092.
   PubMed     Abstract available
   
   
   May 2022
6. TASOUDIS P, Kyriakoulis I, Sagris D, Diener HC, et al
   Clopidogrel monotherapy versus Aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis.
   Thromb Haemost. 2022 May 16. doi: 10.1055/a-1853-2952.
   PubMed     Abstract available
   
   
   
7. ZHANG Y, Zhang Y, Shi X, Lin B, et al
   Clopidogrel versus Ticagrelor in CYP2C19 Loss-of-Function Allele Noncarriers: A Real-World Study in China.
   Thromb Haemost. 2022;122:842-852.
   PubMed     Abstract available
   
   
   April 2022
8. PATTI G, Grisafi L, Spinoni E, Rognoni A, et al
   Safety and efficacy of selective, clopidogrel-based strategies in acute coronary syndrome: a study-level meta-analysis.
   Thromb Haemost. 2022 Apr 18. doi: 10.1055/a-1827-8041.
   PubMed     Abstract available
   
   
   March 2022
9. DEL BIANCO-RONDEAU M, Robert-Halabi M, Bloom S, Rabasa-Lhoret R, et al
   Aspirin for Primary Cardiovascular Prevention in Patients with Diabetes: Uncertainties and Opportunities.
   Thromb Haemost. 2022 Mar 4. doi: 10.1055/s-0042-1743469.
   PubMed     Abstract available
   
   
   
10. MALY M, Riedel T, Stikarova J, Suttnar J, et al
    Incorporation of Fibrin, Platelets, and Red Blood Cells into a Coronary Thrombus in Time and Space.
    Thromb Haemost. 2022;122:434-444.
    PubMed     Abstract available
    
    
    February 2022
11. LOPEZ-GALVEZ R, Rivera-Caravaca JM
    Growth differentiation factor 15 (GDF-15) in cardiovascular diseases: predicting bleeding after cardiac surgery and beyond that!
    Thromb Haemost. 2022 Feb 10. doi: 10.1055/a-1768-4206.
    PubMed     Abstract available
    
    
    
12. NAVARESE EP, Grisafi L, Spinoni EG, Mennuni MG, et al
    Safety and Efficacy of Different Antithrombotic Strategies after Transcatheter Aortic Valve Implantation: A Network Meta-Analysis.
    Thromb Haemost. 2022;122:216-225.
    PubMed     Abstract available
    
    
    January 2022
13. CLELAND JGF
    Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
    Thromb Haemost. 2022 Jan 20. doi: 10.1055/s-0041-1740639.
    PubMed    
    
    
    
14. CANTONI S, Colombo C, Soriano F, Oreglia JA, et al
    RARE CAUSES OF ACUTE CORONARY SYNDROME: THE JAK2 V617F MUTATION POSITIVE MYELOPROLIFERATIVE NEOPLASMS. A cardio-hematological perspective.
    Thromb Haemost. 2022 Jan 17. doi: 10.1055/a-1742-0361.
    PubMed     Abstract available
    
    
    
15. GOROG DA, Massberg S
    NETs in the infarct-related coronary artery - a marker or mediator of adverse outcome?
    Thromb Haemost. 2022 Jan 10. doi: 10.1055/a-1733-9217.
    PubMed     Abstract available
    
    
    
16. CHAO TF, Joung B, Takahashi Y, Lim TW, et al
    2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
    Thromb Haemost. 2022;122:20-47.
    PubMed     Abstract available
    
    
    November 2021
17. BLASCO A, Coronado MJ, Vela P, Martin P, et al
    Prognostic implications of Neutrophil Extracellular Traps in coronary thrombi of patients with ST-elevation myocardial infarction.
    Thromb Haemost. 2021 Nov 30. doi: 10.1055/a-1709-5271.
    PubMed     Abstract available
    
    
    October 2021
18. BOJIC M, Bielesz B, Cejka D, Schernthaner GH, et al
    Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease.
    Thromb Haemost. 2021 Oct 31. doi: 10.1055/s-0041-1736444.
    PubMed     Abstract available
    
    
    
19. MCCUTCHEON K, Manga P
    Human Immunodeficiency Virus and Cardiovascular Disease: Revisiting the Inflammation-Thrombosis Axis.
    Thromb Haemost. 2021 Oct 24. doi: 10.1055/s-0041-1736445.
    PubMed    
    
    
    
20. CALDERONE D, Greco A, Ingala S, Agnello F, et al
    Efficacy and safety of aspirin for cardiovascular risk prevention in younger and older age: an updated systematic review and meta-analysis.
    Thromb Haemost. 2021 Oct 12. doi: 10.1055/a-1667-7427.
    PubMed     Abstract available
    
    
    
21. JEONG YH, Oh JH, Yoon HJ, Park Y, et al
    Pharmacodynamic Profile and Prevalence of Bleeding Episode in East Asian Patients with Acute Coronary Syndromes Treated with Prasugrel Standard-Dose versus De-escalation Strategy: A Randomized A-MATCH Trial.
    Thromb Haemost. 2021;121:1376-1386.
    PubMed     Abstract available
    
    
    September 2021
22. SHARMAN MOSER S, Chodick G, Ni YG, Chalothorn D, et al
    The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events.
    Thromb Haemost. 2021 Sep 23. doi: 10.1055/s-0041-1735971.
    PubMed     Abstract available
    
    
    July 2021
23. VERA A, Rivero F, Salamanca J, Alvarado-Casas T, et al
    Coronary Plaque Erosion after Abemaciclib Treatment Onset: An Unknown Side Effect?
    Thromb Haemost. 2021;121:976-978.
    PubMed     Abstract available
    
    
    June 2021
24. PEDERSEN OB, Grove EL, Kristensen SD, Nissen PH, et al
    MicroRNA as Biomarkers for Platelet Function and Maturity in Patients with Cardiovascular Disease.
    Thromb Haemost. 2021 Jun 6. doi: 10.1055/s-0041-1730375.
    PubMed     Abstract available
    
    
    May 2021
25. HALLY KE, Parker OM, Brunton-O'Sullivan MM, Harding SA, et al
    Linking Neutrophil Extracellular Traps and Platelet Activation: A Composite Biomarker Score for Predicting Outcomes after Acute Myocardial Infarction.
    Thromb Haemost. 2021 May 13. doi: 10.1055/s-0041-1728763.
    PubMed     Abstract available
    
    
    March 2021
26. FABRIS E, Korjian S, Coller B, Ten Berg JM, et al
    Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead.
    Thromb Haemost. 2021 Mar 7. doi: 10.1055/a-1414-5009.
    PubMed     Abstract available
    
    
    February 2021
27. YAMASHITA A, Nishihira K, Gi T, Maekawa K, et al
    Pathological Features of Ruptured Coronary Plaque and Thrombus Interfaces: Fibrin and von Willebrand Factor as Platelet Scaffolds on Rupture Sites.
    Thromb Haemost. 2021;121:234-241.
    PubMed     Abstract available
    
    
    
28. VAN PARIDON PCS, Panova-Noeva M, van Oerle R, Schulz A, et al
    Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample.
    Thromb Haemost. 2021;121:174-181.
    PubMed     Abstract available
    
    
    January 2021
29. GUEDENEY P, Collet JP
    Antithrombotic Therapy in Acute Coronary Syndromes: Current Evidence and Ongoing Issues Regarding Early and Late Management.
    Thromb Haemost. 2021 Jan 27. doi: 10.1055/s-0040-1722188.
    PubMed     Abstract available
    
    
    
30. HENNING C, Branopolski A, Follert P, Lewandowska O, et al
    Endothelial beta1 Integrin-Mediated Adaptation to Myocardial Ischemia.
    Thromb Haemost. 2021 Jan 14. doi: 10.1055/s-0040-1721505.
    PubMed     Abstract available
    
    
    
31. STOJKOVIC S, Wadowski PP, Haider P, Weikert C, et al
    Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary Syndrome.
    Thromb Haemost. 2021 Jan 14. doi: 10.1055/s-0040-1722226.
    PubMed     Abstract available
    
    
    
32. MANDROLA JM, Kaul S, Foy A
    Lessons Learnt from Recent Trials in Ischemic Heart Disease.
    Thromb Haemost. 2021;121:8-14.
    PubMed     Abstract available
    
    
    December 2020
33. AZNAOURIDIS K, Tselegkidi ME, Kanakakis I, Alexopoulos D, et al
    Dual Antithrombotic Therapy in Atrial Fibrillation Patients undergoing Percutaneous Coronary Angioplasty: The Impact of Bleeding Risk Score on Outcome.
    Thromb Haemost. 2020 Dec 30. doi: 10.1055/s-0040-1721777.
    PubMed    
    
    
    
34. ARROYO AB, Aguila S, Fernandez-Perez MP, DE Los Reyes-Garcia AM, et al
    miR-146a in cardiovascular diseases and sepsis: an additional burden in the inflammatory balance?
    Thromb Haemost. 2020 Dec 22. doi: 10.1055/a-1342-3648.
    PubMed     Abstract available
    
    
    
35. CAO YX, Zhang HW, Jin JL, Liu HH, et al
    Lipoprotein(a) and cardiovascular outcomes in patients with previous myocardial infarction: a prospective cohort study.
    Thromb Haemost. 2020 Dec 18. doi: 10.1055/a-1340-2109.
    PubMed     Abstract available
    
    
    
36. KAZEM N, Hofer F, Koller L, Hammer A, et al
    The age-specific impact of cellular immunity on long-term outcome after acute coronary syndrome.
    Thromb Haemost. 2020 Dec 18. doi: 10.1055/a-1340-2055.
    PubMed     Abstract available
    
    
    
37. FABER J, Hvas AM, Kristensen SD, Grove EL, et al
    Immature Platelets and Risk of Cardiovascular Events among Patients with Ischemic Heart Disease: A Systematic Review.
    Thromb Haemost. 2020 Dec 10. doi: 10.1055/s-0040-1721386.
    PubMed     Abstract available
    
    
    
38. LAINE M, Panagides V, Frere C, Cuisset T, et al
    On-ticagrelor platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Thromb Haemost. 2020 Dec 1. doi: 10.1055/a-1326-5110.
    PubMed     Abstract available
    
    
    November 2020
39. MONTALTO C, Ferlini M, Casula M, Mandurino-Mirizzi A, et al
    DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients.
    Thromb Haemost. 2020 Nov 19. doi: 10.1055/s-0040-1721145.
    PubMed    
    
    
    
40. ZOLLER BA, Svensson P, Huang W, Ji J, et al
    Reactome pathway analysis of venous thromboembolism, peripheral artery disease, stroke, and coronary artery.
    Thromb Haemost. 2020 Nov 19. doi: 10.1055/a-1315-2307.
    PubMed     Abstract available
    
    
    
41. KIM HK, Tantry US, Smith SC Jr, Jeong MH, et al
    The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease.
    Thromb Haemost. 2020 Nov 10. doi: 10.1055/s-0040-1718729.
    PubMed     Abstract available
    
    
    October 2020
42. ZHENG YY, Wu TT, Gao Y, Guo QQ, et al
    A Novel ABC Score Predicts Mortality in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Who underwent Percutaneous Coronary Intervention.
    Thromb Haemost. 2020 Oct 31. doi: 10.1055/s-0040-1718411.
    PubMed     Abstract available
    
    
    
43. GENCER S, Lacy M, Atzler D, van der Vorst EPC, et al
    Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19.
    Thromb Haemost. 2020 Oct 29. doi: 10.1055/s-0040-1718735.
    PubMed     Abstract available
    
    
    
44. GUILLET B, Cayla G, Lebreton A, Trillot N, et al
    Long-Term Antithrombotic Treatments Prescribed for Cardiovascular Diseases in Patients with Hemophilia: Results from the French Registry.
    Thromb Haemost. 2020 Oct 24. doi: 10.1055/s-0040-1718410.
    PubMed     Abstract available
    
    
    March 2020
45. PANDEY AK, Xu K, Zhang L, Gupta S, et al
    Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Thromb Haemost. 2020;120:484-494.
    PubMed     Abstract available
    
    
    
46. RAMOTOWSKI B, Gurbel PA, Tantry U, Bracha JS, et al
    Effect of Smoking Cessation on the Pharmacokinetics and Pharmacodynamics of Clopidogrel after PCI: The Smoking Cessation Paradox Study.
    Thromb Haemost. 2020;120:449-456.
    PubMed     Abstract available
    
    
    February 2020
47. KNOPP T, Karbach S, Wenzel P
    Myeloid Cells to the Rescue: Improving Thrombus Resolution.
    Thromb Haemost. 2020;120:197-198.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: